GP5 and infection: The increase of VN antibody titer to GPV following the challenge infection of vaccinated groups (group A1 and A2) was significantly bigger than the increase measured at the same time-interval (3 weeks) in the vaccinated non-challenge group (Table 6 and Figure 6, groups A1, A2, and A3).